Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship
    Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

Press Release 19 March 2024

Award Recipient of 32nd Scott Murphy Memorial Award Lectureship Announced

Press Release 21 Sept 2023

Rebecca Cardigan, PhD elected President, effective Oct 2023

Press Release 07 September 2023

Award Recipient of 31st Scott Murphy Memorial Award Lectureship Announced

BEST LXVII Amsterdam Meeting Countdown Friday, April 12, 2024 08:00 am CEST
14

Member News

  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.
  • The next BEST Meeting will be held in Nashville, TN October 10-11, 2023. Onsite registration will open shortly.
  • We will be also hold this meeting using the Zoom Events format with the same agenda and in Nashiville Time. Pre-registration is required using the individual email sent to each member and approved guest.
  • Please be sure to review the BEST Authorship Policy. BEST Members may find this information in the Members Area > References > Administrative Issues. This area is now searchable.
 

Spring 2024

Amsterdam

BEST Meeting LXVII

The Spring 2024 Meeting is confirmed for Amsterdam, Netherlands

Important News

  • The meeting dates are set for April 12-13, 2024
  • The meeting venue is the DoubleTree by Hilton Amsterdam Centraal Station 
  • A room block is not being established, but a 10% discount will be available at the meeting venue. Details on this and the dinner venue will be available in August 2023.

Fall 2024

Galveston

BEST Meeting LXVIII

The Fall 2024 Meeting is planned for Galveston, TX

Important News

  • The meeting and dinner venues have been confirmed.
  • The AABB Annual Meeting is scheduled for October 19-22, 2204 in Houston. The BEST meeting will be held on October 16-17, 2024. Please note that many of our members have AABB Meetings that they must attend on October 18th.
  • We will announce the arrangement details as soon as they are available.
A A A

The Cellular Therapy Team 

Members of this team work at leading institutions in North America, Europe, Australia, and Asia. Key objectives of the team are to survey current practice in the preparation, assessment, storage and distribution of cellular therapy products and to perform detailed laboratory studies in selected areas of interest. 

Recent and current studies include:

  • Interlaboratory proficiency testing of cord blood stem cell collections
  • Intra and interlaboratory proficiency testing of dendritic cell products for immunotherapy protocols
  • Assessment of stem cell storage and transportation aiming to define best practice
  • Understanding the key release criteria for cellular therapy products
  • Standardization of colony forming units and other key parameters for the assessment of hematopoietic stem cells
  • Measurement of viability of cellular therapy products

The BEST cellular therapy team works closely with international organizations such as AABB, ISCT and EBMT in surveying current practice and its laboratory-based projects are conducted by expert scientists at leading institutions around the world. The results of all studies are published in leading scientific journals such as Transfusion and Cytotherapy. A list of recent publications is to be found on the website. We are keen to continue to forge new scientific links with researchers in other leading academic organizations and with key manufacturers of products used in the field of cellular therapy. We are committed to expanding our interests further into the fields of immunotherapy and regenerative medicine as these are developed for clinical study and subsequent routine application in specific patient groups. We hope that you share our belief that the horizons of cellular therapy are ever-expanding.

The team leaders for Cell Therapy are David McKenna, MD, University of Minnesota, US and David Stroncek, National Institutes of Health, US.